Plantar Ulcers and Neuropathic Arthropathies: Associated Diseases, Polyneuropathy Correlates, and Risk Covariates.


Journal

Advances in skin & wound care
ISSN: 1538-8654
Titre abrégé: Adv Skin Wound Care
Pays: United States
ID NLM: 100911021

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 10 1 2019
medline: 6 8 2019
entrez: 10 1 2019
Statut: ppublish

Résumé

To evaluate the associated diseases, polyneuropathy correlates, and risk covariates of neuropathic plantar ulcers (PUs) and neuropathic arthropathies (NAs). The authors conducted a retrospective, observational study over 3.5 years of 69 patients with neuropathy, NA, or PU seen in a wound clinic who also had a comprehensive neurologic evaluation and neurophysiologic testing. Comparisons were made to a population representative cohort of patients with diabetes mellitus (DM; n = 259). Of the 69 wound clinic patients, 32 had PUs, 14 had NAs, and 23 had both. Of the 61 adequately assessed patients, 37 (61%) had DM, 22 (36%) had no known associated disease, and 2 (3%) had hereditary sensory and autonomic neuropathy. Of the 37 patients with DM, 35 had distal polyneuropathy, and 2 did not. In 22 patients with chronic idiopathic axonal polyneuropathy, 20 had distal polyneuropathy. Although DM was the disease most commonly associated with PUs and NAs, chronic hyperglycemia may not have been the major underlying risk factor. The major risk covariates are sensation loss from polyneuropathy, old age, obesity, repetitive foot injury, and inadequate foot care or treatment. Physicians and other healthcare providers can help by identifying patients at risk and instituting measures such as adequate foot care to decrease these risks.

Identifiants

pubmed: 30624254
doi: 10.1097/01.ASW.0000550591.08674.98
doi:

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Pagination

168-175

Auteurs

Karen L Andrews (KL)

At Mayo Clinic, in Rochester, Minnesota, Karen L. Andrews, MD, is Associate Professor, Department of Physical Medicine & Rehabilitation; Peter J. Dyck, MD, is Roy E. and Merle Meyer Professor of Neuroscience, Division of Neuromuscular Medicine; Steven J. Kavros, DPM, FACCWS, is a Consultant Podiatrist, Department of Orthopedic Surgery; Adrian Vella, MD, is Professor of Medicine, Division of Endocrinology, Diabetes, Metabolism & Nutrition; Mohamed Kazamel, MB, BCh, is Assistant Professor of Neurology, Division of Neuromuscular Medicine; Vicki Clark, BA, CCRP, is a Clinical Researcher, Division of Neuromuscular Medicine; William J. Litchy, MD, is a Neurology Consultant, Division of Neuromuscular Medicine; P. James B. Dyck, MD, is a Neurologist, Division of Neuromuscular Medicine; Karen A. Lodermeier, is Clinical Research Coordinator, Division of Neuromuscular Medicine; Jenny L. Davies, BA, is a Statistical Programmer Analyst, Division of Neuromuscular Medicine; Rickey E. Carter, PhD, is Professor of Biostatistics, Division of Biomedical Statistics and Informatics; and Christopher J. Klein, MD, is a neurologist, Division of Neuromuscular Medicine. The authors have disclosed no financial relationships related to this article. Submitted May 23, 2018; accepted in revised form June 29, 2018.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH